Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 1, 2007, Pages 110-113

  Hope, Russell ^a   Potz, N A C ^a   Warner, M ^a   Fagan, E J ^a   Arnold, E ^a   Livermore, D M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

lactamases; Diagnostic tests; ESBL detection

Indexed keywords

AGAR; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DIAGNOSTIC TEST; ENTEROBACTER; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; INTERMETHOD COMPARISON; KLEBSIELLA; KLEBSIELLA OXYTOCA; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; REFERENCE VALUE; SCREENING TEST; UNITED KINGDOM;

BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 33845892743     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl431     Document Type: Article

References (10)

1. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
2. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev 2005; 18: 657-86.
3. Specialist and Reference Microbiology Division. QSOP 51 Laboratory Detection and Reporting of Bacteria with Extended Spectrum β-Lactamases, 2005. http://www.bsac.org.uk/_db/_documents/ qsop51i1.1.pdf (13 April 2006, date last accessed).
4. Potz NAC, Hope R, Warner M et al. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006; 58: 320-6.
5. Andrews JM. BSAC standardized disc susceptibility testing method (version 4). J Antimicrob Chemother 2005; 56: 60-76.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
7. Potz NA, Mushtaq S, Johnson AP et al. Reliability of routine disc susceptibility testing by the British Society for Antimicrobial Chemotherapy (BSAC) method. J Antimicrob Chemother 2004; 53: 729-38.
8. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004; 42: 5715-21.
9. Livermore DM, Struelens M, Amorim J et al. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother 2002; 49: 289-300.
10. Sturenburg E, Sobottka I, Feucht HH et al. Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum β-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn Microbiol Infect Dis 2003; 45: 29-34.